Clinical trial
ODM 5 in the Treatment of Corneal Edematous Fuchs' Endothelial Dystrophy
NCT02332109 is registered in ClinicalTrials.gov with TRB Chemedica AG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ODM 5 in the Treatment of Corneal Edematous Fuchs' Endothelial Dystrophy
- Lead sponsor
- TRB Chemedica AG
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 30, 2015
- Completion date
- May 31, 2016
- Enrollment
- 29 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.